Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (DE:TEV)
FRANKFURT:TEV
RESEARCH TOOLSreports
Holding DE:TEV?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 4.33B | $ 4.16B | $ 3.82B | $ 4.46B | $ 3.85B |
| Gross Profit | $ 2.15B | $ 2.02B | $ 1.77B | $ 2.42B | $ 1.85B |
| EBIT | $ -321.00M | $ 179.00M | $ 388.00M | $ 694.00M | $ 355.00M |
| EBITDA | $ -62.00M | $ 438.00M | $ 660.00M | $ 960.00M | $ 638.00M |
| Net Income Common Stockholders | $ -437.00M | $ -422.00M | $ -139.00M | $ -197.00M | $ 80.00M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 3.32B | $ 2.26B | $ 2.99B | $ 3.23B | $ 2.25B |
| Total Assets | $ 41.76B | $ 41.34B | $ 42.77B | $ 43.48B | $ 42.09B |
| Total Debt | $ 19.27B | $ 18.92B | $ 19.94B | $ 20.15B | $ 20.30B |
| Net Debt | $ 15.96B | $ 16.66B | $ 16.95B | $ 16.93B | $ 18.05B |
| Total Liabilities | $ 35.38B | $ 31.08B | $ 35.23B | $ 35.35B | $ 34.58B |
| Stockholders Equity | $ 6.07B | $ 10.06B | $ 7.28B | $ 7.51B | $ 6.93B |
| Cash Flow | - | ||||
| Free Cash Flow | $ 545.00M | $ 6.00M | $ -248.00M | $ 1.06B | $ -144.00M |
| Operating Cash Flow | $ 693.00M | $ 103.00M | $ -124.00M | $ 1.18B | $ 5.00M |
| Investing Cash Flow | $ 268.00M | $ 178.00M | $ 144.00M | $ 301.00M | $ 184.00M |
| Financing Cash Flow | - | $ -966.00M | $ -151.00M | $ -576.00M | $ -576.00M |